NVUS - Novus Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPS-3.69-1.53N/AN/A
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.-3.83-3.06-2.7-2.7
EPS Actual-3.69-1.53-1.53-1.32
Difference0.141.531.171.38
Surprise %3.70%50.00%43.30%51.10%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate0000
7 Days Ago-2.34-2.34-9.99-0.39
30 Days Ago-2.34-2.34-9.99-0.39
60 Days Ago-2.34-2.34-9.99-0.39
90 Days Ago-2.34-2.34-9.99-0.39
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesNVUSIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.26
Next Qtr.N/AN/AN/A0.32
Current YearN/AN/AN/A0.09
Next YearN/AN/AN/A0.14
Next 5 Years (per annum)-65.60%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A